Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New protein farnesyltransferase inhibitors in early development at Pfizer

July 3, 2000

Novel caprolactam antitumor agents under study at Novartis

July 3, 2000

Anti-RHAMM monoclonal antibodies useful for proliferative diseases

July 3, 2000

Small molecule from Novartis is a specific inhibitor of cdk4 kinase

July 3, 2000

Novel alkaloids isolated from Daphniphyllum exert cytotoxic effects against cancer cells

July 3, 2000

Kinase inhibitor PKC-412 exhibits both antiproliferative and antiangiogenic properties

July 3, 2000

Tumor growth and spread blocked by inhibition of RAGE-amphoterin interaction

July 3, 2000

FDA approves Targretin gel for treatment of cutaneous T-cell lymphoma

June 30, 2000

Sch-66336 warrants further evaluation for the treatment of glioblastoma multiforme

June 29, 2000

EB-1089 as a potential agent for the management of refractory thyroid carcinoma

June 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...